

Learn about common and serious Viloxazine (Qelbree) side effects, what to watch for, and when you should contact your doctor right away.
Viloxazine (brand name Qelbree) is a non-stimulant medication used to treat ADHD in patients aged 6 and older. Like all medications, it can cause side effects. Knowing what to expect can help you feel more confident about your treatment and know when something needs medical attention.
If you're new to this medication, start with our overview of what Viloxazine is and how it's used.
Most side effects of Viloxazine are mild and may improve as your body adjusts to the medication. The most commonly reported side effects include:
Here are a few practical tips that may help:
While most side effects are mild, there are some serious side effects that require immediate medical attention:
Viloxazine carries an FDA boxed warning about the risk of suicidal thoughts and behavior in children, adolescents, and young adults. This is the most serious warning the FDA can require.
Watch for these warning signs, especially during the first few months of treatment or when the dose is changed:
If you notice any of these signs, contact your doctor right away or call 988 (Suicide and Crisis Lifeline).
Viloxazine can cause increases in blood pressure and heart rate. Your doctor should check your blood pressure and heart rate before starting treatment and periodically during treatment. Tell your doctor if you have a history of heart problems.
In patients with bipolar disorder, Viloxazine may trigger a manic or hypomanic episode. Symptoms include racing thoughts, decreased need for sleep, and unusual risk-taking behavior. Let your doctor know if you have a history of bipolar disorder.
Though rare, allergic reactions can occur. Seek emergency medical help if you experience:
Side effects can vary depending on age. In clinical trials:
Regardless of age, close monitoring is important — especially during the first few weeks and after dose changes.
Compared to stimulant ADHD medications, Viloxazine tends to have a different side effect profile. Stimulants commonly cause loss of appetite, difficulty sleeping, and increased heart rate. Viloxazine shares some of these (decreased appetite, insomnia) but is less likely to cause the jitteriness or anxiety sometimes associated with stimulants.
Compared to Atomoxetine (Strattera), another non-stimulant, Viloxazine has a unique mechanism of action that includes serotonin modulating activity, which may contribute to a different side effect experience.
If side effects become a problem, talk to your doctor about alternative ADHD medications.
Certain medications can interact with Viloxazine and increase the risk or severity of side effects. For a full list, read our guide on Viloxazine drug interactions.
Key interactions to be aware of:
Contact your doctor if you experience:
Don't stop taking Viloxazine without talking to your doctor first. They may want to adjust your dose or switch to a different medication.
If you're currently taking Viloxazine and need to find it in stock, MedFinder can help you check pharmacy availability without calling around. You can also learn about savings programs and coupons to reduce your out-of-pocket costs.
Most Viloxazine side effects are mild and manageable. Drowsiness, decreased appetite, nausea, and headache are the most common. However, the boxed warning about suicidal thoughts — especially in young patients — is important to take seriously. Stay in close contact with your doctor, especially during the first few months of treatment, and don't hesitate to reach out if something doesn't feel right.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.